Leben Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 45.93 Cr
- Satisfied Charges ₹ 36.00 Cr
- Revenue Growth 31.12%
- Profit Growth 16.87%
- Ebitda 80.10%
- Net Worth -157.64%
- Total Assets -2.59%
About Leben Life Sciences
Leben Life Sciences Private Limited (LLSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 17 June 2016 (Eight years and eight months 8 days old ). Its registered office is in Akola, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹45.93 Cr. The company has closed loans amounting to ₹36.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Haresh Shah and Manan Shah serve as directors at the Company.
Company Details
- Location
Akola, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85197MH2016PTC282513
- Company No.
282513
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Leben Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Haresh Shah  | Managing Director | 17-Jun-2016 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manan Shah | Whole-Time Director | 17-Jun-2016 | Current |
Financial Performance of Leben Life Sciences.
Leben Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.12% increase. The company also saw a substantial improvement in profitability, with a 16.87% increase in profit. The company's net worth observed a substantial decline by a decrease of 157.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Leben Life Sciences?
In 2023, Leben Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kyros Corporate Services Private LimitedHaresh Shah is a mutual person
Charges (Loans)
₹45.93 Cr
₹36.00 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 45.93 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2022 | Hdfc Bank Limited | ₹1.50 M | Open |
| 25 Oct 2021 | Hdfc Bank Limited | ₹45.78 Cr | Open |
| 21 Feb 2019 | Others | ₹36.00 Cr | Satisfied |
How Many Employees Work at Leben Life Sciences?
Leben Life Sciences has a workforce of 177 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leben Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leben Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.